Patient leaflet - Verquvo 10 mg film coated tablets
1. What Verquvo is and what it is used for
Verquvo contains the active substance vericiguat, which is a type of heart medicine called soluble guanylate cyclase stimulator.
Verquvo is used to treat adults with long-term heart failure who recently have had an increase in heart failure symptoms. Therefore, you may have gone to hospital and/or received a medicine (diuretic) given in a vein to help you pass more urine than usual.
Heart failure is when your heart is weak and cannot pump enough blood to your body. Some common symptoms of heart failure are shortness of breath, tiredness, or swelling caused by a build-up of fluid.
2. What you need to know before you take Verquvo
Do not take Verquvo if you are
- allergic to vericiguat or any of the other ingredients of this medicine (listed in section 6), – taking any medicine that contains another soluble guanylate cyclase stimulator, e.g. riociguat used to treat high blood pressure in lungs.
If any of the above applies to you, talk to your doctor first and do not take this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before taking Verquvo if you have
- low blood pressure with symptoms like dizziness or light-headedness, – severe kidney problems or are on dialysis,
- severe liver problems.
Children and adolescents
Do not give this medicine to children and adolescents aged under 18 years because it has not been studied yet in this age group.
Other medicines and Verquvo
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, in particular medicines that
- belong to the group of soluble guanylate cyclase stimulators (e.g. riociguat). Do not take Verquvo when taking these medicines. See“Do not take Verquvo”.
- treat high blood pressure in the lungs, or medicines to achieve or maintain an erection, called PDE5 inhibitors (e.g. sildenafil, tadalafil, vardenafil). The use of these medicines is not recommended when taking Verquvo.
treat heart disease including chest pain, called nitrates (e.g. isosorbide mononitrate).
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Verquvo should not be used during pregnancy, as it is not known if it harms the unborn baby. If there is a chance that you could become pregnant, talk to your doctor about reliable forms of contraception.
Breast-feeding
It is not known if Verquvo passes into your breast milk and could harm your baby. Your doctor will decide with you whether breast-feeding or Verquvo therapy should be stopped.
Driving and using machines
If you feel dizzy while taking this medicine, do not drive a vehicle, cycle or use any machines.
Verquvo contains lactose and sodium
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.
3. How to take Verquvo
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended starting dose is 1 tablet of 5 mg once daily. Your doctor will then adjust the dose depending on how well the treatment is tolerated. Typically, your doctor will increase the dose after about 2 weeks to the maximum target dose of 1 tablet of 10 mg once daily.
If you have had low blood pressure within the past 4 weeks, the recommended starting dose is 1 tablet of 2.5 mg once daily. Your doctor will then adjust the dose depending on how well the treatment is tolerated. Typically, your doctor will increase the dose after about 2 weeks to 1 tablet of 5 mg once daily and after about another 2 weeks to the maximum target dose of 1 tablet of 10 mg once daily.
If you have low blood pressure while taking Verquvo, this can make you feel dizzy and light-headed and your doctor may temporarily reduce your Verquvo dose or interrupt your treatment with Verquvo.
Take one tablet at the same time each day with food. If you cannot swallow the tablet, you may crush Verquvo and mix it with water. Take this mixture immediately.
If you take more Verquvo than you should
Contact your doctor immediately if you take more Verquvo than you should and you get any side effects listed in section 4. The most likely effect would be a lowering of your blood pressure which can make you feel dizzy and light-headed.
If you forget to take Verquvo
Take the missed tablet as soon as you remember on the same day of the missed dose. Do not take a double dose to make up for a forgotten tablet.
If you stop taking Verquvo
Do not stop taking this medicine without speaking with your doctor first. If you stop taking this medicine, your condition may worsen.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The possible side effects are:
Very common (may affect more than 1 in 10 people)
- low blood pressure (hypotension)
Common (may affect up to 1 in 10 people)
- low number of red blood cells (anaemia), which can cause pale skin, weakness or breathlessness – dizziness
- headache
- nausea and vomiting
- indigestion (dyspepsia)
heartburn (gastro-oesophageal reflux disease)
305x346-16866_15923 Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Verquvo
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister or bottle after“EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Verquvo contains
- The active substance is vericiguat. Each film-coated tablet contains 2.5 mg, 5 mg or 10 mg vericiguat.
The other ingredients are:
Tablet core: Microcrystalline cellulose, croscarmellose sodium, hypromellose 2910, lactose monohydrate, magnesium stearate, sodium laurilsulfate (see section 2“Verquvo contains lactose and sodium”).
Film-coat: Hypromellose 2910, talc, titanium dioxide (E 171), iron oxide red (E 172) (Verquvo 5 mg only), iron oxide yellow (E 172) (Verquvo 10 mg only).
What Verquvo looks like and contents of the pack
Verquvo 2.5 mg film-coated tablets (tablets) are round, biconvex and white with a diameter of 7 mm, marked with“2.5” on one side and“VC” on the other side.
Verquvo 5 mg film-coated tablets (tablets) are round, biconvex and brown-red with a diameter of 7 mm, marked with“5” on one side and“VC” on the other side.
Verquvo 10 mg film-coated tablets (tablets) are round, biconvex and yellow-orange with a diameter of 9 mm, marked with“10” on one side and“VC” on the other side.
Verquvo is available
- in blisters in cartons of 14, 28 or 98 film-coated tablets
- in perforated unit dose blisters in cartons of 10 × 1 or 100 × 1 film-coated tablets – in bottles of 100 film-coated tablets
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Bayer plc
400 South Oak Way
Reading
RG2 6AD
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
For any information about this medicine, please contact the Marketing Authorisation Holder: Bayer plc
Tel: +44-(0)118 206 3000
This leaflet was last revised in December 2025
B
305x346-16866_15923